MET Gene Renal Cell Carcinoma Papillary Type 1 Familial Genetic Test sale cost 4400 AED
SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test sale cost 4400 AED SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Cancer Targeted Gene Panel CNS Tumor Test sale cost 4680 AED Cancer Targeted Gene Panel CNS Tumor Test Cost 5,200 د.إ Original price was: 5,200 د.إ.4,680 د.إCurrent price is: 4,680 د.إ.
Sale!

MET Gene Renal Cell Carcinoma Papillary Type 1 Familial Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “MET Gene Renal Cell Carcinoma Papillary Type 1 Familial Genetic Test” is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the MET gene, which are closely associated with the development of Papillary Type 1 Renal Cell Carcinoma (RCC). This type of cancer affects the kidneys and is characterized by the growth of small, finger-like projections in the tumor. The familial aspect of this test indicates its importance for individuals with a family history of RCC, as identifying mutations in the MET gene can provide crucial information for early detection, risk assessment, and personalized treatment strategies for family members.

The test is conducted using a sample of the patient’s blood or tissue, where DNA is extracted and analyzed for specific mutations in the MET gene that are known to contribute to the development of this cancer type. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and the specialized technology required to accurately identify these genetic markers.

By opting for this genetic test at DNA Labs UAE, patients and their families can gain valuable insights into their genetic predisposition to Papillary Type 1 RCC, enabling them to make informed decisions about their health management and potentially reducing the risk of developing this type of cancer through early intervention and monitoring.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MET Gene Renal Cell Carcinoma Papillary Type 1 Familial Genetic Test

Are you concerned about your risk of developing familial papillary type 1 renal cell carcinoma (RCC)? DNA Labs UAE offers a comprehensive genetic test that focuses on the MET gene, which is associated with this specific subtype of kidney cancer. Read on to learn more about the test details, cost, symptoms, diagnosis, and more.

Test Name

MET Gene Renal Cell Carcinoma Papillary Type 1 Familial Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the MET Gene Renal Cell Carcinoma Papillary Type 1 Familial Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with MET Gene Renal Cell Carcinoma, papillary type 1, familial NGS Genetic DNA Test gene MET.

Test Details

MET gene renal cell carcinoma, papillary type 1, familial NGS genetic test is a type of genetic test that focuses on the MET gene, specifically looking for mutations or variations in this gene that are associated with familial papillary type 1 renal cell carcinoma (RCC). Renal cell carcinoma is the most common type of kidney cancer, and it can be classified into different subtypes based on its histological features. Papillary type 1 RCC is one of the subtypes, and it is characterized by the presence of papillary structures within the tumor. Familial papillary type 1 RCC refers to cases where there is a hereditary predisposition to develop this specific subtype of kidney cancer. Mutations in the MET gene have been identified as one of the genetic causes of familial papillary type 1 RCC.

NGS (Next-Generation Sequencing) genetic testing is a high-throughput method that allows for the simultaneous analysis of multiple genes. In the context of MET gene RCC testing, NGS can be used to identify mutations or variations in the MET gene that may be associated with an increased risk of developing familial papillary type 1 RCC. This type of genetic test can be useful for individuals with a family history of papillary type 1 RCC or those who have been diagnosed with this subtype of kidney cancer.

Identifying mutations in the MET gene can help in assessing the risk of developing the disease and may have implications for treatment decisions and management strategies. It is important to note that genetic testing should be performed and interpreted by healthcare professionals with expertise in genetics, and genetic counseling should be provided to individuals considering or undergoing genetic testing to fully understand the implications and limitations of the test results.

Test Name MET Gene Renal cell carcinoma papillary type 1 familial Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MET Gene Renal cell carcinoma, papillary type 1, familial NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MET Gene Renal cell carcinoma, papillary type 1, familial NGS Genetic DNA Test gene MET
Test Details

MET gene renal cell carcinoma, papillary type 1, familial NGS genetic test is a type of genetic test that focuses on the MET gene, specifically looking for mutations or variations in this gene that are associated with familial papillary type 1 renal cell carcinoma (RCC).

Renal cell carcinoma is the most common type of kidney cancer, and it can be classified into different subtypes based on its histological features. Papillary type 1 RCC is one of the subtypes, and it is characterized by the presence of papillary structures within the tumor.

Familial papillary type 1 RCC refers to cases where there is a hereditary predisposition to develop this specific subtype of kidney cancer. Mutations in the MET gene have been identified as one of the genetic causes of familial papillary type 1 RCC.

NGS (Next-Generation Sequencing) genetic testing is a high-throughput method that allows for the simultaneous analysis of multiple genes. In the context of MET gene RCC testing, NGS can be used to identify mutations or variations in the MET gene that may be associated with an increased risk of developing familial papillary type 1 RCC.

This type of genetic test can be useful for individuals with a family history of papillary type 1 RCC or those who have been diagnosed with this subtype of kidney cancer. Identifying mutations in the MET gene can help in assessing the risk of developing the disease and may have implications for treatment decisions and management strategies.

It is important to note that genetic testing should be performed and interpreted by healthcare professionals with expertise in genetics, and genetic counseling should be provided to individuals considering or undergoing genetic testing to fully understand the implications and limitations of the test results.

SKU: TEST-4577 Category:

Related products